Merger Arbitrage Tool

Filter by Deal Type:

Note: Premium members can sort this table by Profit, Annualized Profit and Closing Date.

  Symbol Announced Date Acquiring
Company
Deal
Type
Clo.
Value
Clo.
Price
Last
Price
Volume Optionable Div. Yield Clo.
Date
Profit Annu.
Profit
DOYU chart 10/12/2020 HUYA Inc. (HUYA) Stock $3.95 billion $12.57 $7.11 13,413,976 Yes N/A 06/30/2021 76.80% 4672.10%

The following funds have a position in DouYu International Holdings Limited:
1. Omni Partners LLP
2. Pentwater Capital Management LP
3. York Capital Management Global Advisors, LLC

DouYu International Holdings Limited merger details:

Expected to close in the second half of 2021 for a closing value of $3.95 billion in an all stock deal. Under the terms of the agreement, shareholders of DouYu International Holdings will receive 0.730 American depositary shares of Huya, each representing one Huya Class A Share.

Merger Agreement

DouYu International Holdings Limited Investor Relations
HUYA Inc. Investor Relations

DouYu International Holdings Limited Investor Relations

HUYA Inc. Investor Relations

TEDU chart 04/30/2021 Kidedu Holdings Limited (N/A) Cash $230.6 million $4.00 $2.93 400,639 No N/A 09/30/2021 36.52% 136.01%
Tarena International, Inc. merger details:

Expected to close in the third quarter of 2021 for a closing value of $230.6 million. Upon completion of the merger, shareholders of Tarena International will receive $4.00 per share in cash.

Tarena International, Inc. Investor Relations

MX chart 03/26/2021 South Dearborn Limited (N/A) Cash $1.4 billion $29.00 $23.90 209,645 Yes N/A 12/31/2021 21.34% 40.99%

The following funds have a position in Magnachip Semiconductor Corporation:
1. Pentwater Capital Management LP

Magnachip Semiconductor Corporation merger details:

Expected to close in the second half of 2021 for a closing value of $1.4 billion. Upon completion of the merger, shareholders of MagnaChip Semiconductor will receive $29.00 per share in cash.

Merger Agreement

MagnaChip Semiconductor Corporation Investor Relations

Update(s)

May 26, 2021: Outside legal counsel of Magnachip Semiconductor Corporation (MX) and South Dearborn Limited received an e-mail from the U.S. Department of Treasury on behalf of the Staff Chairperson of the Committee on Foreign Investment in the United States. In the e-mail, the CFIUS Staff Chairperson, acting on the recommendation of CFIUS, requested that the parties file a notice concerning the Merger and thereby undergo formal CFIUS review of the Merger.

June 11, 2021: Magnachip Semiconductor Corporation (MX) confirmed receipt of an unsolicited proposal from Cornucopia Investment Partners to acquire all of the outstanding shares of Magnachip common stock for $35.00 per share in cash.

June 15, 2021: Magnachip (MX) received an order from the Treasury Department on behalf of the Committee on Foreign Investment in the United States (CFIUS) telling the company to pause its acquisition by Wise Road Capital until a government review can be completed. The Company is assessing the impact of the Interim Order and the special meeting of stockholders scheduled for June 17, 2021 is expected to be postponed.

June 16, 2021: Magnachip Semiconductor (MX) received a letter from the Korean Ministry of Trade, Industry and Energy (“MOTIE”) requesting MSK to either apply for an approval or file a report, as may be applicable, under Article 11-2 of the Act on Prevention of Divulgence and Protection of Industrial Technology concerning the Merger.

SBBP chart 05/24/2021 Xeris Pharmaceuticals, Inc. (XERS) Stock $267 million $3.39 $2.98 773,910 Yes N/A 11/15/2021 13.65% 34.61%
Strongbridge Biopharma plc merger details:

Expected to close early in the fourth quarter of 2021 for a closing value of $267 million in an all stock deal. Under the terms of the agreement, Strongbridge Shareholders will receive a fixed exchange ratio of 0.7840 Xeris Biopharma Holdings Shares for each Strongbridge Share they own. Strongbridge Shareholders will also receive 1 non-tradeable CVR for each Strongbridge Share they own, worth up to an additional $1.00 payable in cash or Xeris Biopharma Holdings Shares. The minimum payment on the CVR is zero and the maximum payment is $1.00 in cash or Xeris Biopharma Holdings Shares at Xeris Biopharma Holdings’ election.

Merger Agreement

Strongbridge Biopharma plc Investor Relations
Xeris Pharmaceuticals, Inc. Investor Relations

Strongbridge Biopharma plc Investor Relations

Xeris Pharmaceuticals, Inc. Investor Relations

OSN chart 12/17/2020 New Ossen Group Limited (N/A) Cash $84.96 million $5.10 $4.51 8,136 No N/A 06/30/2021 13.08% 795.82%
Ossen Innovation Co., Ltd. merger details:

Expected to close during the first half of 2021 for a closing value of $84.96 million. Upon completion of the merger, shareholders of Ossen Innovation will receive $5.10 in cash per American Depositary Share of the Company.

Merger Agreement

Ossen Innovation Co., Ltd. Investor Relations

Update(s)

June 16, 2021: Ossen Innovation (OSN) announced that it has entered into an Amendment to the Agreement and Plan of Merger to amend its previously announced Agreement and Plan of Merger with New Ossen Innovation Limited. The Merger Agreement provides that either the Company or Parent may terminate the Merger Agreement if the effective time of the merger has not occurred on or before June 17, 2021. Pursuant to Amendment No. 1, the parties have agreed to extend the Termination Date by three months to September 17, 2021.

SJR chart 03/15/2021 Rogers Communications Inc. (RCI) Special Conditions $26 billion $32.40 $28.72 195,572 Yes 2.92% 06/30/2022 12.81% 12.61%

The following funds have a position in Shaw Communications Inc.:
1. Gabelli Funds LLC
2. Magnetar Financial LLC
3. Sand Grove Capital Management LLP

Shaw Communications Inc. merger details:

Expected to close in the first half of 2022 for a closing value of $26 billion. Upon completion of the merger, shareholders of Shaw Communications will receive C$40.5 per share in cash, or $32.40 based on the 80 US cents per CAD exchange ratio.

Merger Agreement

Shaw Communications Inc. Investor Relations

Rogers Communications Inc. Investor Relations

Update(s)

May 20, 2021: Shaw Communications (SJR) announced that its shareholders have overwhelmingly voted in favour of the previously announced plan of arrangement for the proposed business combination with Rogers Communications (RCI).

Note: Premium members can sort this table by Symbol, Profit, Annualized Profit and Closing Date. Desktop Version

  Symbol Clo. Date Profit Annu. Profit
DOYU chart 06/30/2021 76.80% 4672.10%

The following funds have a position in DouYu International Holdings Limited:
1. Omni Partners LLP
2. Pentwater Capital Management LP
3. York Capital Management Global Advisors, LLC

DouYu International Holdings Limited merger details:

Expected to close in the second half of 2021 for a closing value of $3.95 billion in an all stock deal. Under the terms of the agreement, shareholders of DouYu International Holdings will receive 0.730 American depositary shares of Huya, each representing one Huya Class A Share.

Merger Agreement

DouYu International Holdings Limited Investor Relations
HUYA Inc. Investor Relations

DouYu International Holdings Limited Investor Relations

HUYA Inc. Investor Relations

TEDU chart 09/30/2021 36.52% 136.01%
Tarena International, Inc. merger details:

Expected to close in the third quarter of 2021 for a closing value of $230.6 million. Upon completion of the merger, shareholders of Tarena International will receive $4.00 per share in cash.

Tarena International, Inc. Investor Relations

MX chart 12/31/2021 21.34% 40.99%

The following funds have a position in Magnachip Semiconductor Corporation:
1. Pentwater Capital Management LP

Magnachip Semiconductor Corporation merger details:

Expected to close in the second half of 2021 for a closing value of $1.4 billion. Upon completion of the merger, shareholders of MagnaChip Semiconductor will receive $29.00 per share in cash.

Merger Agreement

MagnaChip Semiconductor Corporation Investor Relations

Update(s)

May 26, 2021: Outside legal counsel of Magnachip Semiconductor Corporation (MX) and South Dearborn Limited received an e-mail from the U.S. Department of Treasury on behalf of the Staff Chairperson of the Committee on Foreign Investment in the United States. In the e-mail, the CFIUS Staff Chairperson, acting on the recommendation of CFIUS, requested that the parties file a notice concerning the Merger and thereby undergo formal CFIUS review of the Merger.

June 11, 2021: Magnachip Semiconductor Corporation (MX) confirmed receipt of an unsolicited proposal from Cornucopia Investment Partners to acquire all of the outstanding shares of Magnachip common stock for $35.00 per share in cash.

June 15, 2021: Magnachip (MX) received an order from the Treasury Department on behalf of the Committee on Foreign Investment in the United States (CFIUS) telling the company to pause its acquisition by Wise Road Capital until a government review can be completed. The Company is assessing the impact of the Interim Order and the special meeting of stockholders scheduled for June 17, 2021 is expected to be postponed.

June 16, 2021: Magnachip Semiconductor (MX) received a letter from the Korean Ministry of Trade, Industry and Energy (“MOTIE”) requesting MSK to either apply for an approval or file a report, as may be applicable, under Article 11-2 of the Act on Prevention of Divulgence and Protection of Industrial Technology concerning the Merger.

SBBP chart 11/15/2021 13.65% 34.61%
Strongbridge Biopharma plc merger details:

Expected to close early in the fourth quarter of 2021 for a closing value of $267 million in an all stock deal. Under the terms of the agreement, Strongbridge Shareholders will receive a fixed exchange ratio of 0.7840 Xeris Biopharma Holdings Shares for each Strongbridge Share they own. Strongbridge Shareholders will also receive 1 non-tradeable CVR for each Strongbridge Share they own, worth up to an additional $1.00 payable in cash or Xeris Biopharma Holdings Shares. The minimum payment on the CVR is zero and the maximum payment is $1.00 in cash or Xeris Biopharma Holdings Shares at Xeris Biopharma Holdings’ election.

Merger Agreement

Strongbridge Biopharma plc Investor Relations
Xeris Pharmaceuticals, Inc. Investor Relations

Strongbridge Biopharma plc Investor Relations

Xeris Pharmaceuticals, Inc. Investor Relations

OSN chart 06/30/2021 13.08% 795.82%
Ossen Innovation Co., Ltd. merger details:

Expected to close during the first half of 2021 for a closing value of $84.96 million. Upon completion of the merger, shareholders of Ossen Innovation will receive $5.10 in cash per American Depositary Share of the Company.

Merger Agreement

Ossen Innovation Co., Ltd. Investor Relations

Update(s)

June 16, 2021: Ossen Innovation (OSN) announced that it has entered into an Amendment to the Agreement and Plan of Merger to amend its previously announced Agreement and Plan of Merger with New Ossen Innovation Limited. The Merger Agreement provides that either the Company or Parent may terminate the Merger Agreement if the effective time of the merger has not occurred on or before June 17, 2021. Pursuant to Amendment No. 1, the parties have agreed to extend the Termination Date by three months to September 17, 2021.

SJR chart 06/30/2022 12.81% 12.61%

The following funds have a position in Shaw Communications Inc.:
1. Gabelli Funds LLC
2. Magnetar Financial LLC
3. Sand Grove Capital Management LLP

Shaw Communications Inc. merger details:

Expected to close in the first half of 2022 for a closing value of $26 billion. Upon completion of the merger, shareholders of Shaw Communications will receive C$40.5 per share in cash, or $32.40 based on the 80 US cents per CAD exchange ratio.

Merger Agreement

Shaw Communications Inc. Investor Relations

Rogers Communications Inc. Investor Relations

Update(s)

May 20, 2021: Shaw Communications (SJR) announced that its shareholders have overwhelmingly voted in favour of the previously announced plan of arrangement for the proposed business combination with Rogers Communications (RCI).

Only premium members can access all active mergers and acquisitions. Subscribe today.